Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment
Clinical trial NCT06304025 · UNKNOWN
Trial details
- NCT number
- NCT06304025
- Sponsor
- Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.